Fentanyl Buccal Tablet or Morphine for Exertional Dyspnea in Cancer Patients
Status:
Recruiting
Trial end date:
2025-08-31
Target enrollment:
Participant gender:
Summary
This phase II trial studies fentanyl buccal tablet or morphine to see how well it works
compared to a placebo in controlling shortness of breath during or after physical activity in
cancer patients. Fentanyl sublingual tablet and morphine are opioids normally used to control
pain that may also help to prevent or control shortness of breath during or after physical
activity in cancer patients.